Gregory T. Gallanis

A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer

Kevin McDonnell, Gregory T. Gallanis, Kathleen A. Heller et al. · Cancer Genetics · 2015 · 27 citations

Veterinary Medicine, Genetics, Oncology +16

Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells

Gregory T. Gallanis, Ghada M. Sharif, Marcel O. Schmidt et al. · Cancers · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer

William B. Kietzman, Garrett T. Graham, Virginie Ory et al. · Molecular Cancer Therapeutics · 2019 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

An evaluation of palbociclib as a breast cancer treatment option: a current update

Gregory T. Gallanis, Ramon I. Pericas, Anna T. Riegel et al. · Expert Opinion on Pharmacotherapy · 2020 · 10 citations · Full text

Medicine, Oncology, Pharmacology +16